On September 2, 2022, XPhyto Therapeutics Corp. closed the transaction. On the same date, the company has issued 2,190,000 units for gross proceeds of CAD 788,400 in its third and final tranche bringing the total funds raised in the transaction to CAD 3,600,000.

The company paid CAD 63,072 and issued 175,200 share purchase warrants in finder's fees with respect to the placement. Each finder's warrant is exercisable into one common share at a price of CAD 0.50 per share for a period of two years from the date of issue.